Stalin Dharmayan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stalin Dharmayan has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abiha Abdullah
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
1 shared publication - Charbel Elias
Department of Surgery, Division of Abdominal Organ Transplant Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
1 shared publication - Francis Spitz
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
1 shared publication - Godwin Packiaraj
Department of Surgery, Division of Abdominal Organ Transplant Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
1 shared publication - Jason Mial-Anthony
University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
1 shared publication - Michele Molinari
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
1 shared publication
Latest Publications
- Open Access
Changes and Future Directions in Liver Transplantation in the United States
Liver transplantation (LT) in the United States is evolving in response to shifting disease patterns, innovative therapies, and technological advancements. Metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD) now are the most common indications for LT, reflecting the impact of the obesity epidemic and increased alcohol consumption. Advances in pharmacotherapy for MAFLD and tailored protocols for ALD management are reducing disease progression and improving outcomes. The inclusion of colorectal liver metastases (CRLM) and intrahepatic cholangiocarcinoma (iCCA) as transplant indications highlights progress in chemotherapy and patient selection. Technologies like normothermic machine perfusion (NMP) are expanding the donor pool, while xenotransplantation and organ rehabilitation offer transformative solutions to organ shortages. As the population ages, LT programs must address challenges in older patients and explore minimally invasive approaches for donors and recipients. By integrating innovation and multidisciplinary expertise, LT will continue to provide life-saving care while adapting to the needs of diverse patient populations.
Open AccessChanges and Future Directions in Liver Transplantation in the United States
Liver transplantation (LT) in the United States is evolving in response to shifting disease patterns, innovative therapies, and technological advancements. Metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD) now are the most common indications for LT, reflecting the impact of the obesity epidemic and increased alcohol consumption. Advances in pharmacotherapy for MAFLD and tailored protocols for ALD management are reducing disease progression and improving outcomes. The inclusion of colorectal liver metastases (CRLM) and intrahepatic cholangiocarcinoma (iCCA) as transplant indications highlights progress in chemotherapy and patient selection. Technologies like normothermic machine perfusion (NMP) are expanding the donor pool, while xenotransplantation and organ rehabilitation offer transformative solutions to organ shortages. As the population ages, LT programs must address challenges in older patients and explore minimally invasive approaches for donors and recipients. By integrating innovation and multidisciplinary expertise, LT will continue to provide life-saving care while adapting to the needs of diverse patient populations.